Exploring 489,944 trials

Filters applied: None.

Chlordiazepoxide 8,242 trials

Top Sponsors

  • Riphah International University - (110)
  • Cairo University - (85)
  • National Heart Lung And Blood Institute Nhlbi - (77)

Drug Class: Approved Drug(s)

Drug Type: Small molecular drug

Explore: Chlordiazepoxide globally

Autologous Adipose Derived Stem Cells 4,043 trials

Top Sponsors

  • National Cancer Institute NCI - (206)
  • M D Anderson Cancer Center - (64)
  • Assistance Publique Hopitaux De Paris - (61)

Drug Class:

Drug Type:

Explore: Autologous Adipose Derived Stem Cells globally

Insulin 3,723 trials

Top Sponsors

  • Novo Nordisk A S - (519)
  • Sanofi - (221)
  • Eli Lilly And Company - (175)

Drug Class: Approved Drug(s)

Drug Type:

Explore: Insulin globally

Cyclophosphamide 3,602 trials

Top Sponsors

  • National Cancer Institute NCI - (894)
  • M D Anderson Cancer Center - (163)
  • Childrens Oncology Group - (98)

Drug Class: Approved Drug(s)

Drug Type: Small molecular drug

Explore: Cyclophosphamide globally

Dexamethasone 3,127 trials

Top Sponsors

  • National Cancer Institute NCI - (283)
  • M D Anderson Cancer Center - (91)
  • Celgene - (88)

Drug Class: Approved Drug(s)

Drug Type: Small molecular drug

Explore: Dexamethasone globally

Cisplatin 3,060 trials

Top Sponsors

  • National Cancer Institute NCI - (582)
  • Merck Sharp Dohme LLC - (111)
  • Eli Lilly And Company - (105)

Drug Class: Approved Drug(s)

Drug Type: Small molecular drug

Explore: Cisplatin globally

Carboplatin 2,935 trials

Top Sponsors

  • National Cancer Institute NCI - (544)
  • Merck Sharp Dohme LLC - (130)
  • Astrazeneca - (113)

Drug Class: Approved Drug(s)

Drug Type: Small molecular drug

Explore: Carboplatin globally

Vitamin 2,630 trials

Top Sponsors

  • National Cancer Institute NCI - (44)
  • Cairo University - (41)
  • National Institute Of Diabetes And Digestive And Kidney Diseases Niddk - (37)

Drug Class: Approved Drug(s)

Drug Type:

Explore: Vitamin globally

Gemcitabine 2,624 trials

Top Sponsors

  • National Cancer Institute NCI - (398)
  • Eli Lilly And Company - (173)
  • Astrazeneca - (60)

Drug Class: Approved Drug(s)

Drug Type: Small molecular drug

Explore: Gemcitabine globally

Bevacizumab 2,515 trials

Top Sponsors

  • Genentech INC - (338)
  • National Cancer Institute NCI - (325)
  • Hoffmann La Roche - (234)

Drug Class: Approved Drug(s)

Drug Type: Monoclonal antibody

Explore: Bevacizumab globally